Researchers at the University of Minnesota, world leaders in the treatment of Epidermolysis Bullosa (EB), have developed a stem cell treatment [utilizing mesenchymal stem cells – MSCs] to treat the disorder. This devastating condition involves problems with connective tissue, making skin blister and tear with the slightest contact; severe cases impact internal organ tissues as well. Affecting 1 in every 20,000 children, the disorder can lead to severe infections and be fatal. The team at the University utilized a treatment involving complete renewal of the immune system through chemotherapy and a bone marrow transplant, followed by the administration of mesenchymal stem cells to regenerate the skin tissue.